Search
Octenidine
go.drugbank.com/drugs/DB12624InvestigationalOctenidine is under investigation in clinical trial NCT02697162 (Antiseptic-coated Intermittent Urinary Catheter).
Products: Octenimed 1 mg/ml Lösung zur Anwendung in der Mundhöhle, octenidin schülke 1 mg/ml Lösung zur Anwendung in der MundhöhleDesmopressin
go.drugbank.com/drugs/DB00035ApprovedInvestigationalIt is considered a first-line therapy for central diabetes insipidus but is ineffective in patients with nephrogenic diabetes insipidus, where the kidneys are non-responsive to the hormone [A275458, L56105 … Desmopressin is primarily indicated for the treatment of central diabetes insipidus, primary nocturnal enuresis (bedwetting) in children, and nocturia in adults [A275458, L56104].
Products: Ddavp Inj 4mcg/ml, Octostim Liq Inj. 15mcg/mlTALL-104
go.drugbank.com/drugs/DB17360InvestigationalSynonyms: Human major histocompatibility complex (MHC) non-restricted T-cell line 104, TALL 104DCP-001
go.drugbank.com/drugs/DB17423InvestigationalSynonyms: Proliferation arrested myelomonocytic leukemic cell line-derived cells with a mature dendritic cell phenotypeDiclofenac
go.drugbank.com/drugs/DB00586ApprovedInvestigationalVet approvedDiclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. … It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers.
Mixtures: DermacinRx Lexitral PharmaPak IIProducts: Klofensaid II, LIROKEN-IAtracurium
go.drugbank.com/drugs/DB13295ApprovedInvestigationalWithdrawnProducts: DEMATRAC 25 MG/2.5 ML IV İNFÜZYON İÇİN SOLÜSYON İÇEREN AMPUL, 10 AMPUL, NEUCURIUM 50 MG/5 ML IV INFUZYON VE ENJEKSIYON ICIN COZELTI ICEREN AMPUL, 5 ADETPantoprazole
go.drugbank.com/drugs/DB00213ApprovedInvestigationalevents in patients with unstable coronary syndromes. … [FDA Label] Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread.
Products: Panto IV, CONTROLOC IVEdaravone
go.drugbank.com/drugs/DB12243ApprovedInvestigational[L44007] It was later approved for the treatment of amyotrophic lateral sclerosis (ALS) in Japan and South Korea in 2015, followed by the FDA approval in May 2017 [L41810] and Health Canada approval in … [L44007] The oral suspension formulation of edaravone was approved by the FDA in May 2022 and by Health Canada in November 2022.
Categories: Compounds used in a research, industrial, or household settingProducts: RADICAVA™ IV Concentrate Solution for Infusion 30mg/20mLActivated charcoal
go.drugbank.com/drugs/DB09278ApprovedInvestigationalIt works by binding to the poison in the gastric contents in a reversible fashion thus may be adminstered together with a cathartic to reduce the small intestine transit time. … The clinical applications of activated charcoal occured in the early 1800's.
Categories: Compounds used in a research, industrial, or household settingProducts: NORIT CARBOMIX GRANULES (Activated Charcoal 5g in 6.15g)Cholecystokinin
go.drugbank.com/drugs/DB08862ApprovedInvestigationalWithdrawnNormally, it is an endogenous hormone but is available commercially for diagnostic processes and replacement in pancreatic insufficiency [L1646, L1647, L1648]. in the octapeptide form. … Recent studies have suggested that cholecystokinin also plays a major role in inducing drug tolerance to opioids such as morphine and heroin, and is partially implicated in experiences of pain hypersensitivity
Products: Cholecystokinin Inj 75unit/vial